Vasectomy may NOT raise prostate cancer risk after all: Landmark research 'disproves years of fears over the operation' : dailymail

referring to dailymail

Vasectomy may NOT raise prostate cancer risk after all: Landmark research 'disproves years of fears over the operation'

Vasectomy may NOT raise prostate cancer risk after all: Landmark research 'disproves years of fears over the operation'

Doctors say men should focus on their diet and not smoking to lower riskBut this study is almost 10 times bigger than the 2014 oneIt contradicts high profile Harvard study in 2014 that did find a linkThey found no clear link between vasectomy and prostate cancerVasectomies do not increase a man's risk of getting cancer, the American Cancer Society claims.For years, studies have warned that men who get the snip are far more likely to develop prostate tumors.But a new study backed by some of the leading figures in cancer research concludes there is no evidence to prove that link.'The overall weight of all of the evidence is that vasectomy is unlikely to meaningfully increase risk of any type of prostate cancer,' said Dr. Eric Jacobs, a cancer epidemiologist at the American Cancer Society who led the study.


furthermore news-medical

UCSF researchers receive funding from Susan G. Komen to support breast cancer research

UCSF researchers receive funding from Susan G. Komen to support breast cancer research

Three UCSF researchers have been awarded $680,000 in grants from Susan G. Komen to support projects in breast cancer research.The grants to UCSF were among a total of $32.7 million given to researchers in 23 states and seven countries for projects including research into metastatic disease, novel treatments for aggressive types of breast cancer, new technologies, and health equity.The funds include nearly $1.7 million in new funding for research at four institutions in California, bringing Komen's total research investment in California since 1982 to $76,891,459.The UCSF recipients are:•Komen Scholar Alan Ashworth, Ph.D, FRS, will receive $200,000 to continue his genomics research to identify biomarkers and develop drugs that target these new biomarkers to provide more-effective treatment options for breast cancer that will improve patient outcomes.


in the same way seattletimes

Help fund promising T-cell research to cure kids with cancer

Help fund promising T-cell research to cure kids with cancer

I'll never forget when I covered my first story about a new cancer treatment being developed at Seattle Children's Hospital that seemed at the time like science fiction — T-cell immunotherapy.AS an anchor at KING 5 for more than 40 years, I covered an incredible range of stories, from the most tragic to the awe-inspiring.But there was one topic that was always most near and dear to my heart: health.And more specifically, the health of children in our community.